Utah Medical Products, Inc. (UTMD)
69.16
-1.94
(-2.73%)
USD |
NASDAQ |
Sep 08, 16:00
67.99
-1.17
(-1.69%)
After-Hours: 20:00
Utah Medical Products Market Cap : 220.14M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 220.14M |
| September 04, 2026 | 226.31M |
| September 03, 2026 | 225.07M |
| September 02, 2026 | 228.03M |
| September 01, 2026 | 228.41M |
| August 31, 2026 | 226.41M |
| August 28, 2026 | 231.63M |
| August 27, 2026 | 228.54M |
| August 26, 2026 | 225.64M |
| August 25, 2026 | 225.87M |
| August 24, 2026 | 227.97M |
| August 21, 2026 | 227.74M |
| August 20, 2026 | 227.33M |
| August 19, 2026 | 229.56M |
| August 18, 2026 | 229.18M |
| August 17, 2026 | 223.48M |
| August 14, 2026 | 225.99M |
| August 13, 2026 | 229.49M |
| August 12, 2026 | 229.59M |
| August 11, 2026 | 228.98M |
| August 10, 2026 | 227.04M |
| August 07, 2026 | 225.45M |
| August 06, 2026 | 222.70M |
| August 05, 2026 | 226.65M |
| August 04, 2026 | 230.12M |
| Date | Value |
|---|---|
| August 03, 2026 | 231.55M |
| July 31, 2026 | 224.45M |
| July 30, 2026 | 221.43M |
| July 29, 2026 | 225.79M |
| July 28, 2026 | 225.85M |
| July 27, 2026 | 219.93M |
| July 24, 2026 | 213.69M |
| July 23, 2026 | 204.27M |
| July 22, 2026 | 220.22M |
| July 21, 2026 | 220.09M |
| July 20, 2026 | 220.57M |
| July 17, 2026 | 222.24M |
| July 16, 2026 | 228.42M |
| July 15, 2026 | 224.22M |
| July 14, 2026 | 217.31M |
| July 13, 2026 | 222.91M |
| July 10, 2026 | 216.38M |
| July 09, 2026 | 217.72M |
| July 08, 2026 | 216.70M |
| July 07, 2026 | 220.75M |
| July 06, 2026 | 228.64M |
| July 02, 2026 | 231.73M |
| July 01, 2026 | 224.89M |
| June 30, 2026 | 219.63M |
| June 29, 2026 | 232.65M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 182.59B |
| AngioDynamics, Inc. | 634.68M |
| Alphatec Holdings, Inc. | 1.403B |
| AtriCure, Inc. | 2.733B |
| Baxter International, Inc. | 12.85B |
Market Cap Related Metrics
| PE Ratio | 21.06 |
| PS Ratio | 6.117 |
| Price to Book Value | 1.804 |
| Price to Free Cash Flow | 19.29 |
| Price | 69.16 |
| Earnings Yield | 4.75% |
| Operating PE Ratio | 21.11 |
| Normalized PE Ratio | 20.79 |